Hypertension in pregnancy

Obstetrics and Gynecology Clinics of North America

Volumn 31, Issue 2, 2004, Pages 223-241

  Gregg, Anthony R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETAMETHASONE; CAPTOPRIL; CLONIDINE; DEXAMETHASONE; HYDRALAZINE; LABETALOL; METHYLDOPA; NIFEDIPINE;

BLOOD PRESSURE; CLINICAL TRIAL; HELLP SYNDROME; HOSPITALIZATION; HUMAN; MATERNAL HYPERTENSION; MORBIDITY; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW;

ADRENAL CORTEX HORMONES; ANTIHYPERTENSIVE AGENTS; BED REST; FEMALE; HUMANS; HYPERTENSION; PRACTICE GUIDELINES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RANDOMIZED CONTROLLED TRIALS;

EID: 2942525879     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2004.03.009     Document Type: Review

References (56)

1. ACOG Technical Bulletin. Management of preeclampsia. Pamphlet #91. Washington (DC): American College of Obstetricians and Gynecologists; 1996.
2. Moutquin JM, Garner PR, Burrows RF, Rey E, Helewa ME, Lange IR, et al. Report of the Canadian Hypertension Society Consensus Conference: 2. nonpharmacologic management and prevention of hypertensive disorders in pregnancy. CMAJ 1997;157(7):907-19.
3. National Institutes of Health / National Heart Lung and Blood Institute IH. Working group report on high blood pressure in pregnancy. Washington (DC): National Institutes of Health; 1990.
4. National Institutes of Health / National Heart Lung and Blood Institute. Working group report on high blood pressure in pregnancy. Bethesda (MD): National Institutes of Health; 2000.
5. World Health Organization. Hypertension under specific conditions. Available at: http://www.emro.who.int/Publications/EMRO%20PUB-TPS-hyper-MAN-HSC. htm. Accessed January 21, 2004.
6. Symonds EM. Bed rest in pregnancy. Br J Obstet Gynaecol 1982;89(8):593-5.
7. Browne JC, Veall N. The maternal placental blood flow in normotensive and hypertensive women. J Obstet Gynaecol Br Emp 1953;60(2):141-7.
8. Morris N, Osborn SB, Wright HP. Effective circulation of the uterine wall in late pregnancy measured with 24NaCl. Lancet 1955;268(6859):323-5.
9. Cox LW, Chalmers TA. The effect of preeclamptic toxaemia on the exchange of sodium in the body and the transfer of sodium across the placenta measured by Na24 tracer methods. J Obstet Gynaecol Br Emp 1953;60:214-21.
10. Hon EH, Wohlgemuth R. The electronic evaluation of fetal heart rate. IV. The effect of maternal exercise. Am J Obstet Gynecol 1961;81:361-71.
11. Stembera ZK, Hodr J. Intrauterine dangers to the fetus. Amsterdam: Excerpta Medica Foundation; 1967.
12. Pomerance JJ, Gluck L, Lynch VA. Physical fitness in pregnancy: its effect on pregnancy outcome. Am J Obstet Gynecol 1974;119(7):867-76.
13. Banerjea SK. Index of placental function by endocrine assay and its clinical application in obstetrical practice. J Obstet Gynaecol Br Emp 1962;69:963-78.
14. Courey NG, Stull RL, Fisher B, Stull CG, Lundstrom P. Effect of bed rest upon urinary estriol excretion. Obstet Gynecol 1970;35(2):178-83.
15. Mathews DD, Agarwal V, Shuttleworth TP. The effect of rest and ambulation on plasma urea and urate levels in pregnant women with proteinuric hypertension. Br J Obstet Gynaecol 1980;87(12):1095-8.
16. Mathews DD, Agarwal V, Shuttleworth TP. A randomized controlled trial of complete bed rest versus ambulation in the management of proteinuric hypertension during pregnancy. Br J Obstet Gynaecol 1982;89(2):128-31.
17. Goldenberg RL, Cliver SP, Bronstein J, Cutter GR, Andrews WW, Mennemeyer ST. Bed rest in pregnancy. Obstet Gynecol 1994;84(1):131-6.
18. Curet LB, Olson RW. Evaluation of a program of bed rest in the treatment of chronic hypertension in pregnancy. Obstet Gynecol 1979;53(3):336-40.
19. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996;335(4):257-65.
20. Sibai BM, Barton JR, Akl S, Sarinoglu C, Mercer BM. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 1992;167(4 Pt 1):879-84.
21. Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 1987;70(3 Pt 1):323-7.
22. Sanchez-Ramos L, Adair CD, Kaunitz AM, Briones DK, Del Valle GO, Delke I. Calcium supplementation in mild preeclampsia remote from term: a randomized double-blind clinical trial. Obstet Gynecol 1995;85(6):915-8.
23. Elliott JP, Istwan NB, Jacques DL, Coleman SK, Stanziano GJ. Consequences of nonindicated preterm delivery in singleton gestations. J Reprod Med 2003;48(9):713-7.
24. The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359(9321):1877-90.
25. Scott JR. Magnesium sulfate for mild preeclampsia. (Editorial) Obstet Gynecol 2003;101(2):213.
26. Livingston JC, Livingston LW, Ramsey R, Mabie BC, Sibai BM. Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol 2003;101(2):217-20.
27. Chua S, Redman CWG. Prognosis for pre-eclampsia complicated by 5g or more of proteinuria in 24 hours. Eur J Obstet Gynecol Reprod Biol 1992;43:9-12.
28. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994;171(3):818-22.
29. Schiff E, Friedman SA, Kao L, Sibai BM. The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol 1996;175(5):1313-6.
30. Hall DR, Odendaal HJ, Steyn DW, Grove D. Urinary protein excretion and expectant management of early onset, severe pre-eclampsia. Int J Gynaecol Obstet 2002;77(1):1-6.
31. Practice Bulletin ACOG. Diagnosis and management of preeclampsia and eclampsia. Pamphlet #33. Washington (DC): American College of Obstetricians and Gynecologists; 2002.
32. Schiff E, Friedman SA, Sibai BM. Conservative management of severe preeclampsia remote from term. Obstet Gynecol 1994;84(4):626-30.
33. Sibai BM, Taslimi M, Abdella TN, Brooks TF, Spinnato JA, Anderson GD. Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. Am J Obstet Gynecol 1985;152(1):32-7.
34. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990;76(6):1070-5.
35. Killam AP, Dillard SH, Patton RC, Pederson PR. Pregnancy-induced hypertension complicated by acute liver disease and disseminated intravascular coagulation. Five case reports. Am J Obstet Gynecol 1975;123(8):823-8.
36. Goodlin RC, Cotton DB, Haesslein HC. Severe edema-proteinuria- hypertension gestosis. Am J Obstet Gynecol 1978;132(6):595-8.
37. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142(2):159-67.
38. MacKenna J, Dover NL, Brame RG. Preeclampsia associated with hemolysis, elevated liver enzymes, and low platelets-an obstetric emergency? Obstet Gynecol 1983;62(6):751-4.
39. Weinstein L. Preeclampsia/eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia. Obstet Gynecol 1985;66(5):657-60.
40. Thiagarajah S, Bourgeois FJ, Harbert Jr GM, Caudle MR. Thrombocytopenia in preeclampsia: associated abnormalities and management principles. Am J Obstet Gynecol 1984;150(1):1-7.
41. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin Jr JN. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171(4):1148-53.
42. Magann EF, Perry Jr KG, Meydrech EF, Harris RL, Chauhan SP, Martin Jr JN. Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171(4):1154-8.
43. Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin Jr JN. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1999;181(4):924-8.
44. Martin Jr JN, Perry Jr KG, Blake PG, May WA, Moore A, Robinette L. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol 1997;177(5):1011-7.
45. Tompkins MJ, Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol 1999;181(2):304-9.
46. O'Brien JM, Milligan DA, Barton JR. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000;183(4):921-4.
47. Sibai BM, Taslimi MM, el Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155(3):501-9.
48. National Institutes of Health / National Heart Lung and Blood Institute. Working group report on high blood pressure in pregnancy. Bethesda (MD): National Institutes of Health; 1991.
49. Easterling TR, Carr DB, Davis C, Diederichs C, Brateng DA, Schmucker B. Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy. Obstet Gynecol 2000;96(6):956-61.
50. Caritis SN, Sibai BM, Hauth J. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 1988;338:701-5.
51. Sibai BM, Caritis S, Hauth J. What we have learned about preeclampsia. Semin Perinatol 2003;27(3):239-46.
52. Benedetti TJ. Obstetrics: normal and problem pregnancies. Philadelphia (PA): Churchill Livingstone; 1991.
53. Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003;22(2):203-12.
54. Smulian JC, Ananth CV, Vintzileos AM, Scorza WE, Knuppel RA. Fetal deaths in the United States. Influence of high-risk conditions and implications for management. Obstet Gynecol 2002;100(6):1183-9.
55. Gofton EN, Capewell V, Natale R, Gratton RJ. Obstetrical intervention rates and maternal and neonatal outcomes of women with gestational hypertension. Am J Obstet Gynecol 2001;185(4):798-803.
56. Vigil-De Gracia P, Montufar-Rueda C, Ruiz J. Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation. Eur J Obstet Gynecol Reprod Biol 2003;107(1):24-7.